Literature DB >> 17872367

Age-related alterations in pituitary and testicular functions in long-lived growth hormone receptor gene-disrupted mice.

Varadaraj Chandrashekar1, Christina R Dawson, Eric R Martin, Juliana S Rocha, Andrzej Bartke, John J Kopchick.   

Abstract

The somatotropic axis, GH, and IGF-I interact with the hypothalamic-pituitary-gonadal axis in health and disease. GH-resistant GH receptor-disrupted knockout (GHRKO) male mice are fertile but exhibit delayed puberty and decreases in plasma FSH levels, testicular content of LH, and prolactin (PRL) receptors, whereas PRL levels are elevated. Because the lifespan of GHRKO mice is much greater than the lifespan of their normal siblings, it was of interest to compare age-related changes in the hypothalamic-pituitary-gonadal axis in GHRKO and normal animals. Plasma IGF-I, insulin, PRL, LH, FSH, androstenedione and testosterone levels, and acute responses to GnRH and LH were measured in young (2-4 and 5-6 months of age) and old (18-19 and 23-26 months of age) male GHRKO mice and their normal siblings. Plasma IGF-I was not detectable in GHRKO mice. Plasma PRL levels increased with age in normal mice but declined in GHRKO males, and did not differ in old GHRKO and normal animals. Plasma LH responses to acute GnRH stimulation were attenuated in GHRKO mice but increased with age only in normal mice. Plasma FSH levels were decreased in GHRKO mice regardless of age. Plasma testosterone responses to LH stimulation were attenuated in old mice regardless of genotype, whereas plasma androstenedione responses were reduced with age only in GHRKO mice. Testicular IGF-I mRNA levels were normal in young and increased in old GHRKO mice, whereas testicular concentrations and total IGF-I levels were decreased in these animals. These findings indicate that GH resistance due to targeted disruption of the GH receptor gene in mice leads to suppression of testicular IGF-I levels, and modifies the effects of aging on plasma PRL levels and responses of the pituitary and testes to GnRH and LH stimulation. Plasma testosterone levels declined during aging in normal but not in GHRKO mice, and the age-related increase in the LH responses to exogenous GnRH was absent in GHRKO mice, perhaps reflecting a delay of aging in these remarkably long-lived animals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17872367     DOI: 10.1210/en.2007-0837

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

1.  Effects of sericin on the testicular growth hormone/insulin-like growth factor-1 axis in a rat model of type 2 diabetes.

Authors:  Cheng-Jun Song; Zhen-Jun Yang; Qi-Feng Tang; Zhi-Hong Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Regulation of mTOR activity in Snell dwarf and GH receptor gene-disrupted mice.

Authors:  Graham Dominick; Darlene E Berryman; Edward O List; John J Kopchick; Xinna Li; Richard A Miller; Gonzalo G Garcia
Journal:  Endocrinology       Date:  2014-12-02       Impact factor: 4.736

3.  Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice.

Authors:  William A Banks; John E Morley; Susan A Farr; Tulin O Price; Nuran Ercal; Irving Vidaurre; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

Review 4.  Pituitary senescence: the evolving role of Pttg.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Mol Cell Endocrinol       Date:  2010-02-12       Impact factor: 4.102

Review 5.  Somatotropic signaling: trade-offs between growth, reproductive development, and longevity.

Authors:  Andrzej Bartke; Liou Y Sun; Valter Longo
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

6.  p21(Cip1) restrains pituitary tumor growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Kalman Kovacs; Anat Ben-Shlomo; Kolja Wawrowsky; Serguei Bannykh; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

7.  Cre-mediated recombination in pituitary somatotropes.

Authors:  Igor O Nasonkin; Mary Anne Potok; Sally A Camper
Journal:  Genesis       Date:  2009-01       Impact factor: 2.487

8.  FSH, Bone Mass, Body Fat, and Biological Aging.

Authors:  Mone Zaidi; Daria Lizneva; Se-Min Kim; Li Sun; Jameel Iqbal; Maria I New; Clifford J Rosen; Tony Yuen
Journal:  Endocrinology       Date:  2018-10-01       Impact factor: 4.736

9.  Histological changes of testes in growth hormone transgenic mice with high plasma level of GH and insulin-like growth factor-1.

Authors:  Katarzyna Piotrowska; Sylwia Sluczanowska-Glabowska; Magda Kucia; Andrzej Bartke; Maria Laszczynska; Mariusz Z Ratajczak
Journal:  Folia Histochem Cytobiol       Date:  2015-09-08       Impact factor: 1.698

Review 10.  Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.

Authors:  Zhongbo Liu; Subburaman Mohan; Shoshana Yakar
Journal:  Growth Horm IGF Res       Date:  2015-12-31       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.